CynthiaLouHuffmanMD

Neurology • Tampa, FL

Principal Investigator, Meridien Research Group

Join to view full profile

Are you Dr. Huffman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
501 South Boulevard
Tampa, FL 33606
Phone+1 813-877-8839

Fax+1 813-873-2303
Is this information wrong?

Summary

Dr. Cynthia Huffman, MD is a board certified neurologist in Tampa, Florida. She is currently licensed to practice medicine in Florida, Texas, and Louisiana. She is a Principal Investigator at Meridien Research Group.

Education & Training

Baylor College of MedicineResidency, Neurology, 1981 - 1984
Baylor College of MedicineInternship, Transitional Year, 1980 - 1981
Wright State University Boonshoft School of MedicineClass of 1980

Certifications & Licensure

FL State Medical License 1987 - 2025
TX State Medical License 1983 - 1988
LA State Medical License 1981 - 1987
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Top Doctors: Florida Castle Connolly, 2000

Clinical Trials

A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators Start of enrollment: 2007 Apr 30
Withdrawn
Phase 3
Diazoxide Choline in Hypertriglyceridemia Start of enrollment: 2008 Jun 01
Completed
Phase 2
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01
Terminated
Phase 2
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients Start of enrollment: 2014 Jul 01
Completed
Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Start of enrollment: 2017 Apr 06
Suspended
Phase 2
Join now to see all

Publications & Presentations

PubMed

16 citations
Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomiz...
Cynthia L Huffman, James N Goldenberg, James Weintraub, Luis Sanin, Joseph Driscoll, Ruoyong Yang, Marci L. Chew, Joseph M. Scavone> ;The Clinical Journal of Pain. 2017 Jul 1
22 citations
Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.
Cynthia Huffman, Brett R. Stacey, Michael Tuchman, Claire Burbridge, Chunming Li, Bruce Parsons, Lynne Pauer, Joseph M. Scavone, Regina Behar, Lorraine Yurkewicz> ;The Clinical Journal of Pain. 2015 Nov 1
65 citations
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study...
Edward Fox, Keith R. Edwards, Gordon Burch, Daniel Wynn, Chris LaGanke, Heidi Crayton, Samuel F. Hunter, Cynthia Huffman, Edward Kim, Linda Pestreich, Kevin McCague, L...> ;Multiple Sclerosis and Related Disorders. 2014 Sep 1